LXEO: Lexeo Therapeutics, Inc. Sotuvning sof marjinal rentabelligi

Ommaviy kompaniya Lexeo Therapeutics, Inc. (LXEO) logotipi

Gen terapiyasi sektorida bemorlar uchun kurashayotgan shiddatli raqobat Lexeo Therapeutics (LXEO) aksiyalarining narx dinamikasiga ta'sir ko'rsatmoqda va sof foyda marjasi ushbu qiyinchiliklarni ta'kidlaydi, bunda 0.00 darajasi joriy holatni aks ettiradi. Barqarorlik Altsgeymer va kardiologiya dori vositalarining parallel ishlab chiqilishi orqali ta'minlanmoqda. Shu bilan birga, vektor ishlab chiqaruvchi hamkorlarning kengaytirilgan imkoniyatlari mahsulot ishlab chiqarishning uzluksizligini kafolatlaydi.

LXEO: Lexeo Therapeutics Inc. Sotuvning sof marjinal rentabelligi 21.02.2024 - 19.11.2026

lexeotx.com (LXEO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning asosiy tahlili:Lexeo Therapeutics
Lexeo Therapeutics yetakchi tovari

Institutsional kapital Lexeo Therapeutics (LXEO) faoliyatini daromadlar ololmaslik bosqichidagi kapitalni boshqarish samaradorligi prizmasi orqali baholaydi. Kompaniyaning sof marja profilini tahlil qilish orqali investorlar barcha xarajatlardan keyin qolgan foyda ulushini aniqlashlari mumkin, bu esa ushbu biotexnologiya giganti uchun kapital xarajatlar bo'yicha naqd rezervlarning sarflanish sur'atini aks ettiradi, natijada likvidlikning kamayish tezligi va aktivning umumiy barqarorligi belgilanadi.

Lexeo Therapeutics (LXEO) raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX